# Verismo Therapeutics, . **Source:** https://www.startuphub.ai/startups/verismo-therapeutics **Profile type:** Startup > Developing a novel KIR-based CAR T-cell therapy to overcome T-cell exhaustion and target solid tumors. ## About Verismo Therapeutics is pioneering KIR-CAR T cell therapy, a next-generation approach designed to overcome the limitations of traditional CAR T therapies for solid tumors. Their unique SynKIRâ„¢ platform, inspired by natural killer cell receptors, aims to reduce T cell exhaustion and maintain long-term efficacy in challenging tumor microenvironments. The company is developing this technology for the treatment of solid tumors. ## Key facts - **Slug:** verismo-therapeutics - **Website:** https://verismotherapeutics.com - **Location:** Philadelphia, United States - **Founded:** 2017-01-01 - **Operating status:** Active - **Sectors / tags:** Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, CAR T-cell Therapy, Oncology, Immunotherapy ## Frequently asked ### What does Verismo Therapeutics, . do? Verismo Therapeutics is pioneering KIR-CAR T cell therapy, a next-generation approach designed to overcome the limitations of traditional CAR T therapies for solid tumors. Their unique SynKIRâ„¢ platform, inspired by natural killer cell receptors, aims to reduce T cell exhaustion and maintain long-term efficacy in challenging tumor microenvironments. The company is developing this technology for the treatment of solid tumors. ### Where is Verismo Therapeutics, . headquartered? Verismo Therapeutics, . is headquartered in Philadelphia, United States. ### When was Verismo Therapeutics, . founded? Verismo Therapeutics, . was founded in 2017. ### What industry does Verismo Therapeutics, . operate in? Verismo Therapeutics, . operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, CAR T-cell Therapy. ## JSON-LD Structured data aligned with this page's `